4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-24-002419
Chief Executive Officer acquired 7,179 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-26 | Exercise or conversion : show line 1 in the form | +7,179 | $4.97 | $35,680 | 7,179 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-26 | Exercise or conversion : show line 2 in the form Options to purchase common stock | −7,179 | $4.97 | $35,680 | 0 | D |
Loading xslF345X05/doc4.xml…